Applications for new human medicines under evaluation: February 2026

List of medicines currently in PRIME scheme

Human medicines European public assessment report (EPAR): DuoTrav, travoprost,timolol, Date of authorisation: 23/04/2006, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Avzivi, bevacizumab, Date of authorisation: 26/07/2024, Revision: 2, Status: Authorised

Procedural advice for vaccine platform technology master file (vPTMF) certification

Procedural advice for veterinary vaccine antigen master file (VAMF) certification

Human medicines European public assessment report (EPAR): Tocilizumab STADA (previously Tofidence), tocilizumab, Date of authorisation: 20/06/2024, Revision: 4, Status: Authorised

HMPC meeting report on European Union herbal monographs, guidelines and other activities - 19-21 January 2026

European Medicines Agency’s data protection notice for EudraVigilance Human (EV)

Human medicines European public assessment report (EPAR): Prevenar 13, pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), Date of authorisation: 09/12/2009, Revision: 50, Status: Authorised